Jiří P.
- Country
- Czechia
- Department
- PreventaMed s.r.o.
Research Overview
- Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Duvakitug for Induction Therapy in Moderately to Severely Active Crohn's Disease
- Efficacy and Safety of Duvakitug for Maintenance Therapy in Participants with Moderately to Severely Active Crohn’s Disease: A Phase 3, Randomized, Placebo-Controlled Study
- Long-term Safety, Tolerability, and Efficacy of Balinatunfib in Adults with Crohn's Disease or Ulcerative Colitis: A Multicenter Extension Study
Data & Insights
Has run more than one trial at 1108 of 1966 partner sites.
Specializations
Inflammatory Bowel Disease
Specializes in treating ulcerative colitis and Crohn's disease, with particular attention to developing innovative therapeutic approaches for patients with moderate to severe manifestations.
- Novel biologics evaluation
- Treatment-resistant IBD
- Bowel urgency management
Focuses on both induction and maintenance therapy strategies for long-term disease control.
Cardiovascular and Metabolic Disorders
Investigates treatments for atherosclerotic cardiovascular disease, atrial fibrillation, and complex metabolic conditions including hypertriglyceridemia.
- Cardiovascular risk reduction
- Lipid management
- Heart failure prevention
Expertise in evaluating therapeutic combinations for optimal cardiovascular outcomes.
Renal and Metabolic Medicine
Conducts research in chronic kidney disease management, particularly in patients with concurrent hypertension and metabolic disorders such as type 2 diabetes.
- Renal function preservation
- Blood pressure control
- Metabolic disease management
Specializes in combination therapy approaches for complex renal conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.